Neil Edwards has been overweight his entire life, but when he saw the effect Mounjaro had on his sister he decided he had to try the weight-loss jab for himself ...

Lilly gains CDSCO approval to launch Mounjaro KwikPen in India, challenging Novo Nordisk’s Wegovy in obesity drug market.

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 ...

The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to ...

India's clinical trial industry has surged into the top three globally, driven by regulatory reforms, affordability, vast ...

Wegovy, the ₹26K/month weight-loss jab, hits India with bold promises—from fat loss to heart health. But is this pharma fix a ...

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a fast-growing market.